Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS may soon show whether AI can start to replace call centers
10:13pm, Thursday, 20'th Jun 2024
Companies are increasingly turning to AI to see if it can improve the customer service experience. CVS plans to use AI so that pharmacy customers don't have to go through a menu option, per The Wall S
The Schall Law Firm Is Investigating Claims Pertaining To CVS Health Corporation And Invites Its Shareholders To Join The Probe
01:15pm, Thursday, 20'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
Inside CVS's Strategy to Improve the Pharmacy Experience
09:00am, Thursday, 20'th Jun 2024
When it comes to customer experience at the nation's largest retail pharmacy chains, there is plenty of room for improvement, according to Tilak Mandadi, the chief digital, data, analytics and technol
LOS ANGELES, CA / ACCESSWIRE / June 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
3 Must-Buy Stocks for Long-Term Gains: June 2024
07:00am, Wednesday, 19'th Jun 2024
Investors must be cautious about the kinds of stocks with the most growth potential and good fundamentals to maximize returns while minimizing risks. Key fundamentals should lie at the helm of the str
The Schall Law Firm Is Investigating Claims Related To CVS Health Corporation And Invites Its Investors To Join The Probe
03:00pm, Tuesday, 18'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
05:57pm, Saturday, 15'th Jun 2024
Pfizer stock has been beaten down so far that it offers a dividend yield above 6% at recent prices. Bristol Myers Squibb has been trading for the low multiple of about 7 times trailing free cash flow.
Maximize Profits with These 3 Discounted Stocks Set to Skyrocket
06:29am, Friday, 14'th Jun 2024
The investment landscape is buzzing with potential for those willing to dive into the world of discounted stocks. Amidst a recovering global economy and shifting market dynamics, certain sectors are s
Is CVS Health Stock a Millionaire Maker?
05:15am, Friday, 14'th Jun 2024
CVS Health has many businesses which will allow it to benefit from growth opportunities in the healthcare industry. The company consistently generates strong free cash flow.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
10:06am, Wednesday, 12'th Jun 2024
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
CVS brand drug recall: are factories tainted?
05:56am, Tuesday, 11'th Jun 2024
CVS has recalled #genericdrugs at higher rates than its peers, a potentially dangerous pattern that has roots in the quality of #pharmaceuticals factories Sign up for The Big Take newsletter, one stor
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
10:35am, Monday, 10'th Jun 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corporation - CVS
12:00pm, Sunday, 09'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or the "Company") (NYSE:CVS). Such investors are advised to con
